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Hepatic progenitor cells (HPCs) are bipotential stem cells that can differentiate into mature hepatocytes
or biliary epithelial cells (BECs). They are thought to be involved in repair of liver injury and the incidence
of hepatic carcinoma. Their physiology is closely associated with the microenvironment where they
reside. Lipopolysaccharide (LPS), an important component of the hepatic pathological microenviron-
ment, is stored in the liver and affects many types of cells in various hepatosis. HPCs may also be
inﬂuenced by LPS. In this paper, mouse ED13.5 E-cadherinþ foetal liver cells were isolated as mouse
hepatic progenitor cells (mHPCs). Proliferation of mHPCs was promoted under LPS conditions both
in vivo and in vitro. Moreover, LPS enhanced colony formation ability of mHPCs, and blocked them
differentiation into mature hepatocytes and formation of a bile duct-liked structure. More importantly,
long-term treatment with LPS promoted tumorigenesis of mHPCs in nude mice. Thus, we conclude that
LPS may promote aberrant proliferation of mHPCs and restrict their normal differentiation. Long-term
exposure of mHPCs to LPS increased the risk of tumour formation. These data provide insight into the
links between LPS, HPCs fate, and tumorigenesis, and present novel insight into the relationship between
HPCs and their microenvironment.
© 2016 The Author(s). Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
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er Ireland Ltd. This is an open acceor biliary epithelial cells (BECs) [17,27]. In general, HPCs remains
dormant until they are activated by a severe injury to the liver. They
have been demonstrated to be involved in liver regeneration and
injury repair. However, some studies have suggested that HPCs are
the origin of liver cancer stem cells (CSCs) [1,2]. CSCs, a subpopu-
lation of cancer cells endowed with self-renewal and differentia-
tion capacities, have been suggested to be associated with
tumorigenesis, tumour development, and prognosis. Based on their
similar phenotype, normal stem cells were considered the resource
of CSCs [44]. In the hematopoietic system and solid tissues with a
high rate of cell turnover, stem cells have long been thought to be
responsible for tumor formation [30,36,43]. Cancer is widely
accepted to be a disease of stem cells, since they are the cells that
persist in the tissue for a sufﬁcient length of time to acquire the
requisite number of genetic changes for neoplastic development
[2]. Some liver cancer cells have been reported to express HPC
markers [8]. Saha, S. K. et al. found that blocking hepatocyte dif-
ferentiation promoted the occurrence of biliary cancer [35]. Thisss article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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their normal differentiation is restricted.
The physiology of HPCs is closely related to the microenviron-
ment in which they reside. Lipopolysaccharide (LPS) is the major
component of the cell wall of all Cram-negative bacteria cell
[14,25,28,51]. During all types of hepatic disease, disturbance of the
enteric ﬂora results in the gut-originated LPS translocation. In
addition, LPS production is increased and the excess is stored in the
liver owing to the disturbance of enteric ﬂora and the damage to
liver metabolic function. Studies have suggested that LPS accumu-
lation affects the physiology of various types of cells in the liver,
including macrophages [10,26], lymphocytes [23], dendritic cells
[13] and parenchymal cells [16,46,53]. And LPS also has a signiﬁcant
effect on adult stem cells. Schuster A et al. found that LPS could
induce the secretion of several cytokines and enhance the prolif-
eration of enteric neural stem/progenitor cells (NSPCs) in a dose-
dependent manner [37]. In addition, Li C et al. found that LPS
could decrease the osteogenic potential of human periodontal lig-
ament stem cells by activating TLR4-regulated NF-kB [22]. Another
study found that LPS could inhibit the adipogenic potential of
adipocyte progenitors [55]. Furthermore, as the receptor of LPS,
Toll-liked receptor 4 (TLR4), was found be expressed on HPCs in
HCV-related chronic liver disease [50]. All of the above results
suggested that LPS plays an important role in the function of adult
stem cells, including proliferation, differentiation, and physical
function. and it can alter the physiology of HPCs.
To test our hypothesis, we used 3,5-diethoxycarbony-1,4-
dihydrocollidine (DDC) to induce pathological HPCs activation in
mice [11,32,34,41]. This model has often been used to study the
physiology of HPCs, because it shows effective activation of HPCs
and a severe bile duct reaction (BDR) and cholestasis, but leads to
low mortality. When we used an antibiotic to limit LPS production
[31,38], we observed less BDR, HPCs, and cholestasis in the DDC-
plus-antibiotic group than in the DDC-alone group. This result
indicated that more mHPCs would be activated under LPS condi-
tions. LPS accelerated the course of liver disease, and had a negative
effect onmice. To verify whether LPS had a direct effect on HPCs, we
isolated E13.5 E-cadherinþ foetal liver cells from C57BL/J6 mice as
mHPCs (mouse hepatic progenitor cells), using methods described
in previous reports [6,27,29,48], and found that the mHPCs
expressed TLR4. The mHPCs were treated with different does of
LPS. The results showed that LPS enhanced the proliferation and
colony formation abilities of mHPCs. To test whether LPS affected
the normal differentiation of mHPCs, we built a differentiation
systems and found that LPS not only blocked mHPCs from differ-
entiating into mature hepatocytes but restricted formation of bile-
duct liked structures. This result indicated that HPCs would be
activated by LPS, but they would not be able to perform their
normal functions under LPS treatment. LPS induced aberrant acti-
vation of HPCs. Further, we investigated whether LPS could affect
neoplastic transformation of mHPCs. After two months of LPS
treatment, mHPCs were transplanted into nude mice. The results
showed that normal mHPCs did not form tumours, but mHPCs that
had heen subject to long-term treatment with mHPCs did.
Thus, we concluded that LPS could promote the proliferation
and enhance the stemness of mHPCs. LPS also inhibited the normal
differentiation of mHPCs and promoted neoplastic transformation
of mHPCs. Regulating the production of LPS in patients, it may alterFig. 1. Inhibiting LPS production reduced HPCs activation and cholestasis in mice. (A) Schem
different groups. (C) Representative H&E images of the livers from different groups. (D, E) Re
related statistic data. (F, G) Representative IHC images of liver from different groups stained w
levels of ALT, and AST of mice in different group. (J) Serum levels of TBIL, DBIL, and IBIL of m
signiﬁcant) mean ± S.E.M.the effects of HPCs on liver disease and guide the development of
new clinical therapy.
Materials and methods
Isolating foetal mouse E-cadherinþ cells as mHPCs
In order to isolate and purity mouse hepatic progenitor cells, we modifed the
method to isolate HPCs on the basis of previous reports [6,27,29,48]. Firstly, we
removed foetal liver tissue from C57BL/6 mice at day 13.5 of gestation. And then
foetal liver tissue was dissociated to obtain hepatic cell suspension after enzymatic
digestion for 60 min at 37 C. E-cadherinþ cells was isolated from hepatic cell sus-
pension with immunomagnetic beads and seeded into ultra-low attachment dish in
mouse embryonic ﬁbroblasts condition medium (MEF CM). Hepatic spheroids were
formed and collected at day 6 and plated on type I collagen-coated dishes in MEF
CM. After 2 weeks, hepatic spheroids were treated with trypsin and collagenase and
then replanted on type I collagen-coated dishes for another 2 weeks. MEF CM was
changed every two days. After that, hepatic progenitor cells were harvested from
collagen-coated dishes and cultured in MEF CM to maintain the stemness of cells on
normal dishes. We regarded DMEM/F12 medium with 10% fetal bovine serum, 1%
penicillin/streptomycin as standard medium to conduct the further experiments.
Flowchart for obtaining mHPCs is shown in Fig. 2A.
Animal model
Male C57BL/6J mice (6e8 weeks old, weighting 20e25 g) obtained from
Shanghai Laboratory Animal Center and housed in pathogen-free conditions. Animal
protocols were approved by the Second Military Medical University Animal Care
Committee. DDCmodel: Themicewere divided into four groups: control, DDC, DDC-
plus-antibiotic and antibiotic groups. DDC-plus-antibiotic and antibiotic group were
given antibiotic (penicillin 1 g/L, gentamycin 1 g/L, metronidazole 1 g/L, vancomycin
0.5 g/L) into the drinking water 2 weeks before DDC feed until the end of the study.
Mice were fed special diet containing 0.1% DDC feed for 2 weeks. The experiment
was presented in Fig. 1A.
To investigate the effect of LPS on neoplastic transformation of subcutaneously
implanted mHPCs xenografts in nude mice. MHPCs were cultured under LPS treat-
ment for 2 months. After that 1  106 normal mHPCs and LPS-treated mHPCs were
transplanted into nude mice (6e8 weeks, weighting 20e23 g).
Differentiation of hepatic progenitor cells
For hepatocytes differentiation, 0.5 106mHPCswere cultured on 10 cm culture
dishes in hepatocytes differentiation induced media (HDM, MDEM/F-12 medium
added 10% fetal bovine serum, 1% penicillin/streptomycin, 10 ng/ml mouse oncos-
tatin M, 20 ng/ml mouse HGF and 100 nM dexamethasone) for 2e3 weeks [45]. For
BECs differentiation, we modiﬁed the method reported previously [35,47]. 1:1
mixture of Matrigel and type I collagen solutionwas coated onto 6 cm culture dishes
and allowed to set for 1 h. Then 0.5  106 mHPCs were plated on the dishes in BECs
differentiation induce medium (BDM, MDEM/F-12 medium added 10% fetal bovine
serum, 1% penicillin and 100 ng/ml HGF) for 3 days. Differentiation media were
changed every day.
Immunohistochemistry (IHC) and immunoﬂuorescence (IF)
For IHC and IF assays, cells were cultured on glass coverslips, ﬁxed with 4%
paraformaldehyde, then permeabilized in PBS containing 0.2% Triton X-100, and
blocked with 1% bovine serum albumin (BSA). Primary antibodies incubated over-
night at 4 C. For IHC assays, the glass coverslips were washed by PBS and incu-
bated with secondary antibodies conjugated to horseradish peroxidase for 1 h at
37 C. Add freshly prepared DAB substrate to the section and incubate until stain
develops. Then nuclesus counter stained with hematoxylin. For IF assays, the glass
coverslips were washed by PBS-Tween and incubated with ﬂuorescence antibody as
secondary antibody for 1 h at 37 C.Then the glass coverslips were washed by PBS-
Tween and cell nucleus stained with DAPI.
Periodic-acid-Schiff's stain (PAS)
For detection of the differentiated condition into hepatocytes, we used periodic-
acid-Schiff's staining kit (Leagene, Beijing) to test glycogen storage in the differen-
tiated cells. Cells cultured in HDM for 2e3 weeks, and then ﬁxed in 4% formalin for
15 min, and stained following the manufacturer's instruction.atic of animal experiment (See Methods for details). (B) The morphology of the liver in
presentative IHC images of the livers from different groups stained with pan CK and the
ith Ki67 and the related statistic data. (H) Weight of mice in different groups. (I) Serum
ice in indifferent groups. (*P < 0.05, **P < 0.01, ***P < 0.001, and NS corresponds to not
Fig. 2. Isolation E-cadherinþ mHPCs from foetal liver. (A) Flowchart for obtaining E-cadherinþ mHPCs from mouse foetal liver. (B) The morphological changes of mHPCs during cell
culture. (C) Immunoﬂuorescence stain was used to identify the phenotypes (E-cadherin, Epcam, pan CK, AFP, ALB and CK19) of the cultured cells.
X.-Y. Li et al. / Cancer Letters 386 (2017) 35e4638Flow cytometry
For cell cycle analysis, cells were washed with cold 1X PBS three times and were
digested to obtain monoplast suspension. Cells were ﬁxed with 70% ethanol over-
night at 4 C, washed with PBS cells and incubated with propidium iodide staining
buffer (BD Biosciences) for 30 min at 37 C. Flow cytometric analysis was carried out
using a FACSCalibur ﬂow cytometer (BD Biosciences) and CellQuest software. Cell
cycle distribution was analyzed using FlowJo software.Colony-formation assay
The Colony-forming assay was performed according to previous report [12].
Brieﬂy, 500 cells were in 6-well plates in standardmediumwith LPS (10 mg/ml) for 2
weeks. Colonies formed were stained with 0.5% (w/v) crystal violet prepared in
0.6% (v/v) glutaraldehyde solution.Sphere-formation assay
Sphere-formation assay was performed in 6 cm culture dish coated with 1%
agarose. HPCs suspended in serum freemediumwere seeded at a density 5000 cells/
dish and incubated for 3e7 days. The numbers and size of sphere were observed
manually under microscope.Proliferation assays
The Cell Counting Kit-8 (cck8) assay for determining proliferation of mHPCs:
5  103 cells in 96-well microplates in different dose LPS (0-100 mg/ml). Cells were
cultured at 37 C for 12 h, 24 h and 36 h. To test the mechanism of LPS on HPCs, Cells
were cultured for 24 h under different treatment. The number of viable cells was
measured by adding 10% cell counting Kit-8 (CCK-8) assay according to the manu-
facturer's instructions.
Real-time reverse transcription polymerase chain reaction (real-time RT-PCR)
Total RNAwas isolated using TRIZOL (Invitrogen, Carlsbad, CA, USA) according to
the manufacturer's protocol. RNA was quantiﬁed using an ND-2000 spectropho-
tometer (Nanodrop Technologies, Wilmington, DE) and complementary DNA syn-
thesis was performed using the PrimeScript RT reagent Kit (Takara, Kyoto, Japan).
Real-time PCR was per-formed using SYBR PrimeScript RT-PCR Kit (Applied BI). The
relative quantities of mRNAs were obtained by using the comparative Ct method and
were normalized withb-actin. The sequences of PCR primers are shown in Table 1.
Western blot
Cells were washed by phosphate-buffered solution (137 mmol/L NaCl, 2.7 mM/L
KCl,10mM/L Na2HPO4, 2 mM/L KH2PHO4, PH 7.4) for 3 times. Total cellular proteins
Fig. 3. LPS promoted proliferation and colony formation of mHPCs. (A) Detect whether mHPCs could express TLR4 by immunoﬂuorescence. (B) Detect the inﬂuence of LPS on
proliferation of mHPCs by CCK-8 at the time of 12, 24 and 36 h. (C) Comparing the inﬂuence of LPS on mHPCs proliferation by CCK-8 at 36 h (*P < 0.05, **P < 0.01, ***P < 0.001, and
NS corresponds to not signiﬁcant) mean ± S.E.M. (D) mHPCs cell cycle analysis was performed using ﬂow cytometry after treated 10 mg/ml LPS for 24 h. (E) Quantiﬁcation of the
fraction of mHPCs in different cell cycle with or without LPS. (F) Analysis the inﬂuence of different dose of LPS on colony formation and (G) sphere-formation of mHPCs.
X.-Y. Li et al. / Cancer Letters 386 (2017) 35e46 39were extracted using cell lysis buffer (Beyotime) with 1 mM PMSF. The protein
concentrations of the lysates were determined according to the bicinchoninic acid
(BCA) method. Equal amount of protein was separated by 20% sodium dodecyl
sulfateepolyacrylamide gel electrophoresis (SDS-PAGE). After electrophoresis, the
proteins were transferred to a polyvinylidene diﬂuoride membrane for western blotanalysis. Membranes were blocked with 20% skim milk for 2 h. Primary antibodies
incubated over-night at 4 C. The membranes were washed by TBS-Tween and
incubatedwith secondary antibodies conjugated to horseradish peroxidase for 1 h at
37 C. Immunoreactive proteins were developed by using the BeyoECL (Beyotime)
and Tanon 5200 system.
Table 1
The primers were used in this experiment.
Epcam Forward GGAGTCCCTGTTCCATTCTTCT
Reverse GCGATGACTGCTAATGACACCA
Foxl1 Forward TTTCAGCATCGACAGCATCTT
Reverse AGACCAGCGAAGCGTTGAAG
DLK Forward AGTGCGAAACCTGGGTGTC
Reverse GCCTCCTTGTTGAAAGTGGTCA
ALB Forward CAAGAGTGAGATCGCCCATCG
Reverse TTACTTCCTGCACTAATTTGGCA
Hnf4a Forward ACACGTCCCCATCTGAAGGTG
Reverse CTTCCTTCTTCATGCCAGCCC
Hnf1a Forward AGGAGTGTAATAGGGCGGAGT
Reverse GAGGTCCGTTATAGGTGTCCA
CK19 Forward GGGGGTTCAGTACGCATTGG
Reverse GAGGACGAGGTCACGAAGC
Sirt1 Forward ATGACGCTGTGGCAGATTGTT
Reverse CCGCAAGGCGAGCATAGAT
b-actin Forward GGCTGTATTCCCCTCCATCG
Reverse CCAGTTGGTAACAATGCCATGT
X.-Y. Li et al. / Cancer Letters 386 (2017) 35e4640Results
Limitating the production of intestinal LPS could effectively reduce
the activation of HPCs and alleviated liver disease in mice
DDC-fed animals are the classic model for studying the physi-
ology of HPCs. DDC triggers severe BDR, HPCs activation, and
cholestasis. LPS eliminationwas performed as previously described,
using an antibiotic in the drinking water [31,38]. This method can
effectively reduce the level of LPS in DDC-fed animals
(Supplementary Fig. S1). Mice were divided into four groups:
control, DDC, DDC-plus-antibiotic, and antibiotic groups. We added
the antibiotic into the drinking water 2 weeks before beginning
DDC feeding to limit gut-LPS production. Mice were then fed DDC
for 2 weeks (Fig. 1A). The results suggested that DDC led the liver to
become dark brown, but the colour of the liver in the DDC-plus-
antibiotic group was close to the normal colour (Fig. 1B). In addi-
tion, limitation of the production of intestinal LPS signiﬁcantly
reduced BDR and the activation of mHPCs (Fig. 1CeG). Thus, more
mHPCs would be activated under LPS conditions. Insterestingly, the
mice in DDC-plus-antibiotic group were in better condition. ALT
and AST did not differ signiﬁcantly between the DDC-added-
antibiotic group and the DDC group (Fig. 1I). However, mice in
the DDC-added-antibiotic group had a higher bodyweight (Fig.1H).
Cholestasis was effectively reduced by limiting LPS production
(Fig. 1J). These results indicated that LPS would contributes to the
course of liver disease.Isolation E-cadherinþ mHPCs from ED13.5 foetal liver
To investigate the inﬂuence of LPS on HPCs, we isolated E-
cadherinþ mHPCs from ED13.5 foetal livers for further study. Em-
bryonic mouse foetal liver was used as a reliable source of HPCs. E-
cadherin, a marker of HPCs, was used to identify and isolate HPCs
[27,49]. We isolated mouse liver progenitor cells using a modiﬁed
version of a previously reported method [6,29,48], and puriﬁed the
mHPCs by targeting E-cadherin (Fig. 2A). During the procedure, we
observed the morphological changes in the mHPCs. When plated
on the adherent dishes, they became polygonal in shaped and
showed typical HPCs characteristics (Fig. 2B). Next, we identiﬁed
the isolated mHPCs by detecting mHPCs markers (E-cadherin,
EpCAM, pan CK, and AFP), a mature hepatocyte marker (ALB), and a
BECs marker (CK19) (Fig. 2C). mHPCs abundantly expressed E-
cadherin, EpCAM, and pan CK, but only a small portion of themHPCs expressed AFP. Moreover, although many mHPCs can
expressed ALB and CK19, their power of their ﬂuorescence was
weak.
LPS promoted proliferation and colony formation of mHPCs
In the above experiment, we observed that more mHPCs were
activated under LPS conditions. However, it remained unclear
whether this was a direct effect of LPS on mHPCs. To test this, we
used E-cadherinþ mHPCs to conduct further studies. We found
that mHPCs can strongly express TLR4 strongly, as assessed by
immunoﬂuorescence (Fig. 3A). We used different concentrations
of LPS to treat mHPCs, and measured cells viability by MMT
analysis at 12, 24, and 36 h. The results showed that 10 mg/mL LPS
clearly promoted HPCs proliferation, but the other dosages (0.1 mg/
mL and 1 mg/mL) did not signiﬁcantly affect proliferation (Fig. 3B,
C). However, 100 mg/ml LPS showed the opposite effect. Based on
the MMT resluts, we further tested the inﬂuence of 10 mg/mL LPS
on the cell cycle of mHPCs. Cell cycle analysis by ﬂow cytometry
showed a higher S phase fractions in HPCs under LPS treatment
(Fig. 3D, E). Combined with the previous results, this indicated that
LPS accelerated DNA replication in mHPCs. Further, we found that
10 mg/mL LPS promoted colony formation and sphere formation in
mHPCs (Fig. 3F, G), suggesting that LPS enhances the stemness of
mHPCs.
LPS caused excessive proliferation via the NF-kB signalling pathway
To determine the molecular mechanism of LPS-induced prolif-
eration of mHPCs, we targeted the NF-kB signalling pathway, which
has been reported to be associated with the effect of LPS [9,15]. We
found that the NF-kB signalling pathway was activated by LPS
(Fig. 4A). We administered an NF-kB inhibitor (BAY 11-7082) to
treat the mHPCs, and found that BAY 11-7082 effectively reduced
the level of p-IkBa, p-P65 (Fig. 4B). In addition, the increased pro-
liferation and colony formation abilities of mHPCs would be
restricted (Fig. 4C, D). Flow cytometry analysis showed that the
increase in the number of cells in S phase caused by LPS was also by
BAY 11-7082 (Fig. 4E). This indicated that LPS induced excessive
proliferation of mHPCs via activation of the NF-kB signalling
pathway. In addition, phosphorylation of P38, and ERK were also
increased by LPS stimulation (Supplementary Fig. S2). But there
was no signiﬁcant change of phosphorylation of JNK. Thus, the
MAPK signalling pathway may also play a role in the inﬂuence of
LPS on HPCs.
LPS inhibited differentiation of mHPCs into mature hepatocytes
differentiation and formation a bile duct-liked structure
HPCs are considered to be bipotential precursors and potentially
suitable for treating end-stage liver disease. However, in the above
experiments, we observed that treatment with mHPCs did not
improve liver disease in the DDC group. Limitation of LPS produc-
tion reducedmHPCs activation, but improved the condition of mice
in the DDC-added-antibiotic group. Thus, we suspected that LPS
affects the function of mHPCs. To test this hypothesis, we built an
mHPCs differentiation system to observe the role of LPS on it. We
used oncostatin (OSM), dexamethasone (DXM), and hepatocyte
growth factor (HGF) to induce differentiation of mHPCs into mature
hepatocytes [45]. After 2e3 weeks, periodic acid-Schiff reagent
(PAS) was used to determine differentiation. The results indicated
that LPS inhibited mHPCs from differentiating into mature hepa-
tocytes (Fig. 5A). We next determined the expression levels of he-
patocytes markers (ALB, Hnf1a, HNF4a) in differentiated mHPCs.
LPS treatment reduced the expression of ALB, Hnf1a and HNF4a in
Fig. 4. LPS caused excessive proliferation via the NF-kB signalling pathway. (A) Western blot for induction of pIKB-a, IKB, p-P65 and P65 in mHPCs with or without LPS treatment.
(B) Western blot for induction of pIKB-a, p-P65 and P65 with or without LPS and BAY 11-7082 treatment. (C) Analysis the inﬂuence of BAY 11-7082 on proliferation of mHPCs with
LPS treatment by CCK-8 at 24 h. (D) Analysis the inﬂuence of BAY 11-7082 on sphere-formation of mHPCs with LPS treatment by sphere-formation assay. (E, F) mHPCs cell cycle
analysis was performed using ﬂow cytometry with LPS or/and BAY 11-7082 treatment. (*P < 0.05, **P < 0.01, ***P < 0.001, and NS corresponds to not signiﬁcant) mean ± S.E.M.
X.-Y. Li et al. / Cancer Letters 386 (2017) 35e46 41
Fig. 5. LPS inhibited mHPCs from differentiating into mature hepatocytes. (A) Representative image of PAS stain of cells at day 14. (BeD) RT-PCR for induction of the hepatocyte
markers ALB Hnf1a and Hnf4a (E) Western blot for induction of the hepatocyte markers ALB Hnf1a and Hnf4a (F) Western blot for induction of the WNT signalling pathway relative
protein Wnt3a and active-b catenin. (*P < 0.05, **P < 0.01, ***P < 0.001, and NS corresponds to not signiﬁcant) mean ± S.E.M.
X.-Y. Li et al. / Cancer Letters 386 (2017) 35e4642mRNA (Fig. 5BeD) and protein levels (Fig. 5E). We also investigated
a key hepatocyte differentiation signalling pathway, the Wnt sig-
nalling pathway. We found that LPS reduced the level of Wnt sig-
nalling (Fig. 5F).
Further, we induced differentiation of mHPCs into BECs in 3D
culture [35,47]. LPS treatment inhibited mHPCs from forming a
bile-duct liked structure (Fig. 6A). Levels of the BEC marker were
reduced in the LPS treatment group (Fig. 6B, C). In addition, a key
BEC differentiation signalling pathway, the Notch signaling
pathway, was inhibited by LPS (Fig. 6C). These results were similar
to those for hepatocyte differentiation. All of these results show
that LPS interfered with the normal differentiation of HPCs.
Long-term treatment with LPS induced neoplastic transformation of
mHPCs
In the above research, we found that LPS promoted proliferation
and enhanced the colony formation ability of mHPCs, while it
restricted the normal differentiation of mHPCs. Excessiveproliferation and blocked differentiation have been demonstrated
to be early events of tumorigenesis. We suspected that mHPCs
would undergo neoplastic transformation under LPS treatment. To
test this, we cultured mHPCs for two months under LPS treatment.
Normal mHPCs and LPS-treated mHPCs were subcutaneously
transplanted into nude. After 3 weeks, tumour were detected in all
mice transplanted with LPS-treated mHPCs, whereas those trans-
planted with normal mHPCs did not form tumours (Fig. 7AeC).
H&E staining and IHC were used to observe the morphological
characteristcs of these tumor tissue. The texture of the tumour was
tight, and karyokinesis was obvious (Fig. 7D). In addition, imuno-
histochemical staining showed a high rate of cells proliferation
(Fig. 7E) and a small number of E-cadherinþ cells (Fig. 7F). Tmours
also showed ﬁbrous septa (Fig. 7G) and numerous CK19þ cells were
observed in tunmor (Fig. 7H).
Overall, LPS caused excessive proliferation and enhanced the
colony formation of mHPCs ability via NF-kB signalling. LPS pre-
vented normal differentiation of mHPCs and induced aberrant
activation and neoplastic transformation of mHPCs.
Fig. 6. LPS inhibited mHPCs from forming the bile-duct liked structure in 3D culture. (A) Analysis the ability of forming-the bile duct liked structure of mHPCs in 3D culture with or
without LPS treatment at day 3. (B) RT-PCR for induction of the BECs marker CK19. (C) Western blot for induction of the BECs marker CK19 and Notch signalling pathway relative
protein Notch1. (*P < 0.05, **P < 0.01, ***P < 0.001, and NS corresponds to not signiﬁcant) mean ± S.E.M.
X.-Y. Li et al. / Cancer Letters 386 (2017) 35e46 43Discussion
HPCs show self-renewal and biphasic differentiation capacities
[3]. The fate of HPCs is related to the microenvironment in which
they reside. It has been reported that some components of the
liver microenvironment affect activation and differentiation of
HPCs, including EGF, HGF [18], TGFb [11], extracellular matrix
(ECM), and Kupffer cells [5] among others. Previous reports have
suggested that HPCs are involved in liver regeneration and injury
repair by differentiating into hepatocytes and BECs. Trans-
plantation of HPCs is considered a potential new technology for
the replacement of liver transplantation for patients with end-
stage liver disease. However, there are barriers to implementa-
tion, including the lack of a reliable source of HPCs and the low
cell survival rate after transplantation. Two additional risks are
involved: HPCs may aggravate liver injury, and HPCs may turn
into CSCs. Kuramitsu et al. investigated the ﬁbrogenic role of
HPCs in ﬁbrotic rat liver via the TWEAK signalling pathway [19].
The degree of HPC activation has been shown to be correlated
with the severity of liver ﬁbrosis [7,33]. The results indicated that
HPCs are important not only in liver regeneration but also in liver
ﬁbrosis.
More importantly, HPCs are considered the origin of hepatoma
stem cells [52]. They are long-lived cells that are capable ofsurviving long enough to accumulate DNA damage [4]. They are
able to multiply rapidly after continuous, severe liver damage. This
signiﬁcantly increases the risk of stem cell mutation and is an
indispensable process for malignant transformation [56]. Indeed,
gene expression proﬁling has identiﬁed a subset of hepatic carci-
nomas with poor prognosis that have a proﬁle consistent with an
origin from HPCs [21]. Accumulation of HPCs increases the risk of
hepatoma, especially when their normal differentiation is
restricted [35]. Studies suggest that if tumours do arise from HPCs,
this indicates a block in HPC differentiation, a process termed ‘stem
cell maturation arrest’ [39,40]. These data are consistent with those
of our work.
In this study, we investigated the inﬂuence of LPS on prolifera-
tion and differentiation of HPCs, and investigated the mechanism
by which LPS promoted mHPC proliferation and colony formation
ability. LPS promoted proliferation of mHPCs in vivo and in vitro.
We also observed that LPS accelerated the course of liver disease,
but it was unclear whether this resulted directly from the inﬂuence
of LPS on HPCs. In addition, LPS inhibited mHPC differentiation into
mature hepatocytes and formation of a bile ductelike structure. It
also prevented them from performing their normal functions. Thus,
it is possible that LPS induces aberrant differentiation of mHPCs,
leading to liver disease. Above all, we observed mHPCs formed
tumours in nude mice after long-term treatment with LPS. One
Fig. 7. Long-term treatment with LPS induced neoplastic transformation of mHPCs. (A) Normal mHPCs and LPS-treated mHPCs were subcutaneously transplanted into nude mice to
analyze the tumorigenesis abilities. (B) Rate of tumor formation in nude mice. (C) The image of tumor arising from LPS-treated mHPCs. (D) Representative H&E images of tumor.
(EeH) Representative IHC images of Ki67, E-cadherin, a-SMA, CK19 of tumor.
X.-Y. Li et al. / Cancer Letters 386 (2017) 35e4644possible reason is that excessive proliferation increases the likeli-
hood of mutation of HPCs. Normal differentiation of mHPCs is also
blocked by LPS. These two factors are thought to be signiﬁcant early
events in tumorigenesis. LPS is also considered a proinﬂammatory
factor. More and more studies have identiﬁed a close connection
between inﬂammation and tumorigenesis. The effect of inﬂam-
mation on tumours manifests in several aspects: it is involved in
DNA damage and genomic instability, epithelial-mesenchymal
transition (EMT), and activation of cancer-associated signalling
pathways.
We found that LPS activated NF-kB signalling inmHPCs, which is
also thought to be closely related to the occurrence and develop-
ment of tumours. A high level of NF-kB-enhanced metastasis has
been found in various cancers, such as hepatoma [42], gastriccarcinoma [54], breast cancer [24] and others. LPS was found to
support maintenance of the fraction of hepatoma stem cells by NF-
kB/HIF1a [20]. Overall, we demonstrated that NF-kB has a pro-
proliferation effect on mHPCs. However, it remains unclear
whether stem cell maturation arrest is involved; if yes, the under-
lying mechanism also remains unknown. These aspects require
further investigation.
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